| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_716e9a2606ffd4ba1a2a3917e4a402fd |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2021-6439
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-115
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2506-45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2015-149
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-105
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2501-727 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0658
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-6428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N15-1434
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-10 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
| filingDate |
2016-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab504b5feccd7a238b8893f53a69b498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_21440a8c909bf07b34bcdde574537b3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d3f3a333bdd6bb0b165ef09fc661894d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ae35d9d640ff7bd81b4588abf704650
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4d18c26c4f8de0b0be314c4b0b3a1b50 |
| publicationDate |
2016-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2016114354-A1 |
| titleOfInvention |
Method for selecting skeletal muscle progenitor cell |
| abstract |
The present invention addresses the problem of providing a method for selecting a skeletal muscle progenitor cell from a cell group including skeletal muscle progenitor cells. The problem is solved by providing a step for introducing miRNA-responsive mRNA into the cell group. The miRNA-responsive mRNA contains: (i) a nucleic acid containing a sequence specifically recognized by miRNA that is specifically expressed in skeletal muscle progenitor cells; and (ii) a nucleic acid containing a sequence that codes for a marker protein. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2019031595-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7236738-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017073600-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2019013294-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7318931-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019031595-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019013294-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2017073600-A1 |
| priorityDate |
2015-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |